Consistently, IHC detection of tumor xenografts showed that the levels of β-catenin, c-Myc, and Cyclin D1 were significantly reduced in the mice administered SM compared to those treated with vehicle (Fig. S5A-D). The gene discussed is MYC; the disease is neoplasm.